Atossa Therapeutics ATOS
NASDAQ ATOS
$2.27 +0.32 (+16.41%)
At close: Oct 1, 2026 · 4:00 PM EDT

Atossa Therapeutics (ATOS) Current Leases (2014 - 2015)

Updated

Atossa Therapeutics (ATOS) reported Current Leases of $72,338 for Q2 2015, down 9.5% from the prior quarter.

Analysis

Atossa Therapeutics (ATOS) Current Leases (2014 - 2015) Analysis & Trends

At the end of FY2014, Atossa Therapeutics posted Current Leases of $76,025.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 274.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -2.32 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Atossa Therapeutics 19.46 Mn 19.46 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2015 72,338.00
Mar 31, 2015 79,974.00
Dec 31, 2014 76,025.00
API Access

Atossa Therapeutics Current Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-leases&ticker=ATOS&period=max&api_key=YOUR_API_KEY